jeudi 24 septembre 2015

Onco Actu du 24 septembre 2015

2.5 Etiologie - Gènes

Researchers develop strategy for determining how non-coding gene sequences contribute to disease risk [Massachusetts General Hospital]

2.6 Etiologie - Environnement

Could Dark Matter Cause Cancer? [MIT Technology Review]

4.9 Dép., diag. & prono. - Sein

DCIS dilemma: Dr. Laura Esserman podcast [HealthNewsReview]

5.2 Pharma

Pfizer Says It Could Be Leader in Cancer With Many New Drugs [ABC News]

CTI heads to the FDA with its Baxalta-partnered cancer drug [FierceBiotech]

OncoGenex Announces Phase 2 Rainier Results in Previously Untreated Metastatic Pancreatic Cancer [OncoGenex]

OncoGenex's pancreatic cancer drug found ineffective in study [Reuters]

Amgen, Allergan say Avastin copycat succeeds in lung cancer study [Reuters]

5.2.3 Pharma - économie

Shkreli, Turing, and PhRMA [In the Pipeline]

5.3 Traitements - FDA, EMA,...

Seeing is believing: Making clinical trial statistical data from medical product testing easy to understand [FDA Voice]

5.4 Traitements - Economie

The price isn’t right, but neither is the effect [The Cancer Blog]

NICE says yes to new class of drug for adults with leukaemia [NICE]

NICE backs Gilead's novel leukaemia drug for NHS use [Pharma Times]

How Prescription Drugs Get So Wildly Expensive [WIRED]

UK cancer patients being denied drugs due to inflated prices, say experts [The Guardian]

5.6 ESMO

Myriad Genetics Presents New Data on Its Companion Diagnostic and Prostate Cancer Tests at the European Society for Medical Oncology Annual Meeting [Myriad]

Clovis Oncology Announces Data Presentations at 2015 European Cancer Congress [Clovis Oncology]

AstraZeneca presents advances in oncology research at ECC 2015 with data on AZD9291, durvalumab and LYNPARZA™ (olaparib) [AstraZeneca]

6. Lutte contre les cancers

Bold Blueprint for Precision Medicine Initiative’s Research Cohort [NIH Director's Blog]

Here's how to keep clinical trial participants honest (and why that's a big deal) [Retraction Watch]

6.1 Observation

Getting active after a cancer diagnosis may extend life [Reuters]

6.6 Publications

ESMO Announces Christoph Zielinski as Editor-in-Chief 
of New Open Access Journal [ESMO]

ASCO Publishes First Articles in New Journal of Global Oncology [ASCO]

6.7 DMP, Big Data & applis

ASCO Applauds IOM Report "Improving Diagnosis in Health Care" [ASCO]

6.7.2 Applis

Do we need to rethink regulation for health apps? [PHG Foundation]

6.9 Controverses

Parents of Ashya King put him at risk, report says [The Guardian]